Company / Return on Assets (ROA)
Beta Bionics, Inc. Return on Assets (ROA) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-22.3%
FY2025
5-year range
-40.1% / -22.3%
FY2023-FY2025
Trend
+39.1%
vs FY2024
Sector context
#147 of 159
Health Care
What the data says
Among 159 Health Care companies, Beta Bionics, Inc. is in the bottom 8% for return on assets (roa). Improved from -40.1% to -22.3% over the past 2 years.
Based on SEC 10-K filings.
-22.3% in FY2025.
Improved from -40.1% to -22.3% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 159This company -22.3% Sector average -2.2%
▼
-906.8% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 39.1% year-over-year.
- Currently 20.1pp below the Health Care sector average.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -22.3% | +39.1% |
| FY2024 | -36.6% | +8.7% |
| FY2023 | -40.1% | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026